Phase II study of i.v. vinflunine as second line in patients with metastatic breast cancer after anthracycline-taxane failure

被引：0
|
作者：
Fumoleau, P
Campone, M
Vorobiof, D
Casado, M
Ruff, P
Kei, SK
Cortes-Funes, H
Khalfallah, S
Caroff, I
Colin, C
机构：
[1] Ctr George Francois Leclerc, Dijon, France
[2] CRLC Nantes Atlantique, Ctr Rene Gauducheau, St Herblain, France
[3] Saridton Oncol Ctr, Johannesburg, South Africa
[4] Univ Witwatersrand, Johannesburg, South Africa
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp 12 Octubre, E-28041 Madrid, Spain
[7] Inst Salah Azaiz, Tunis, Tunisia
[8] Inst Rech Pierre Fabre, Boulogne, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
542
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [41] Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer
    Kosmas, C
    Agelaki, S
    Giannakakis, T
    Mavroudis, D
    Kouroussis, C
    Kalbakis, K
    Papadouris, S
    Souglakos, J
    Malamos, N
    Georgoulias, V
    ONCOLOGY, 2002, 62 (02) : 103 - 109
  • [42] Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine.
    Thomas, E.
    Perez, E. A.
    Mukhopadhyay, P.
    Lerzo, G.
    Pivot, X.
    Bosserman, L. D.
    Mullaney, B.
    Vahdat, L.
    Hortobagyi, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [43] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [44] Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials
    Atalay, G
    Biganzoli, L
    Renard, F
    Paridaens, R
    Cufer, T
    Coleman, R
    Calvert, AH
    Gamucci, T
    Minisini, A
    Therasse, P
    Piccart, MJ
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (17) : 2439 - 2449
  • [45] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Ford, Hugo E. R.
    Yap, Yoon-Sim
    Miles, David W.
    Makris, Andreas
    Hall, Marcia
    Miller, Liz
    Harries, Mark
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) : 809 - 815
  • [46] A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
    Pivot, X.
    Koralewski, P.
    Hidalgo, J. L.
    Chan, A.
    Goncalves, A.
    Schwartsmann, G.
    Assadourian, S.
    Lotz, J. P.
    ANNALS OF ONCOLOGY, 2008, 19 (09) : 1547 - 1552
  • [47] Phase I/II study of paclitaxel and 5-fluorouracil as second-line therapy in patients with metastatic breast cancer
    Gleissner, B
    Hellmann, A
    Berdel, WE
    Edler, L
    Koldehoff, M
    Rost, A
    Opri, F
    Fritze, D
    Öhl, S
    ONKOLOGIE, 1998, 21 (04): : 305 - 308
  • [48] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Donadio, M
    Ardine, M
    Berruti, A
    Ritorto, G
    Fea, E
    Mistrangelo, M
    Coccorullo, Z
    Bergnolo, P
    Comandone, A
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 147 - 152
  • [49] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Michela Donadio
    Mara Ardine
    Alfredo Berruti
    Giuliana Ritorto
    Elena Fea
    Marinella Mistrangelo
    Zaira Coccorullo
    Paola Bergnolo
    Alessandro Comandone
    Oscar Bertetto
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 147 - 152
  • [50] Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
    Burstein, Harold J.
    Elias, Anthony D.
    Rugo, Hope S.
    Cobleigh, Melody A.
    Wolff, Antonio C.
    Eisenberg, Peter D.
    Lehman, Mary
    Adams, Bonne J.
    Bello, Carlo L.
    DePrimo, Samuel E.
    Baum, Charles M.
    Miller, Kathy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1810 - 1816
12345